Available in 12
locations and 7
We explore the first order under the new interim measures Arrangement that came into effect on 1 October 2019.
Read on for issues that biotech companies should watch out when planning a listing by Ch.18A of the HK Main Board.
This article describes what happened to the AlphaBay takedown, and how such “dark net marketplaces” operate.
Corruption and bribery are live issues. This article sets out four tips on how you can manage corruption risks.
China’s growing middle class and aging population is driving demand for improved health and aged care services and products.
The United Kingdom’s Modern Slavery Act is now in force. This article sets out seven things you need to know to protect your business.
Preparing for Competition Commission investigations
HK Competition Commission’s enforcement and leniency policies
Accept and Close